Skip to main content
Erschienen in: Diseases of the Colon & Rectum 2/2007

01.02.2007

Prognostic Groups in 1,676 Patients with T3 Rectal Cancer Treated without Preoperative Radiotherapy

verfasst von: Morten T. Eriksen, M.D., Arne Wibe, M.D., Ph.D., Jon Haffner, M.D., Ph.D., Johan N. Wiig, M.D., Ph.D., on behalf of The Norwegian Rectal Cancer Group

Erschienen in: Diseases of the Colon & Rectum | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Purpose

The use of preoperative radiotherapy in patients with T3 tumors shows considerable variation among countries and institutions. The Norwegian guidelines have been very restrictive, limiting the indication to T4. This study was designed to identify subgroups of patients with T3 tumors with presumed high risks on adverse outcome and to use these results to reevaluate the national guidelines for preoperative radiotherapy.

Methods

This was a national cohort study of 2,460 patients with pT3 rectal adenocarcinoma, undergoing major surgery without preoperative radiotherapy from November 1993 to December 2002. Circumferential resection margin in millimeters was given for 1,676 patients.

Results

Multivariate analyses identified circumferential resection margin and nodal status as independent prognostic factors for local recurrence, metastases, and overall mortality. Analyses based on 12 combinations of N stage and circumferential resection margin showed that the estimated five-year rate of local recurrence increased from 11.1 percent (circumferential resection margin >3 mm; N0) to 36.5 percent (circumferential resection margin ≤1 mm; N2). The rate of distant metastases increased from 18.5 to 77.7 percent and the five-year survival decreased from 68.6 to 25.7 percent, respectively.

Conclusions

There is great variation in outcome for patients with T3 cancers, and the outcome is not acceptable for the groups of patients with circumferential resection margin <3 mm or involved lymph nodes. These groups should be considered for neoadjuvant therapy.
Literatur
1.
Zurück zum Zitat Heald, RJ, Moran, BJ, Ryall, RD, Sexton, R, MacFarlane, JK 1998Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997Arch Surg133894899PubMedCrossRef Heald, RJ, Moran, BJ, Ryall, RD, Sexton, R, MacFarlane, JK 1998Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997Arch Surg133894899PubMedCrossRef
2.
Zurück zum Zitat Wibe, A, Moller, B, Norstein, J, et al. 2002A national strategic change in treatment policy for rectal cancer–implementation of total mesorectal excision as routine treatment in Norway. A national auditDis Colon Rectum4585766PubMedCrossRef Wibe, A, Moller, B, Norstein, J,  et al. 2002A national strategic change in treatment policy for rectal cancer–implementation of total mesorectal excision as routine treatment in Norway. A national auditDis Colon Rectum4585766PubMedCrossRef
3.
Zurück zum Zitat Martling, A, Holm, T, Johansson, H, Rutqvist, LE, Cedermark, B 2001The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based studyCancer92896902PubMedCrossRef Martling, A, Holm, T, Johansson, H, Rutqvist, LE, Cedermark, B 2001The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based studyCancer92896902PubMedCrossRef
4.
Zurück zum Zitat Kapiteijn, E, Marijnen, CA, Nagtegaal, ID, et al. 2001Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancerN Engl J Med345638646PubMedCrossRef Kapiteijn, E, Marijnen, CA, Nagtegaal, ID,  et al. 2001Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancerN Engl J Med345638646PubMedCrossRef
5.
Zurück zum Zitat Law, WL, Ho, JW, Chan, R, Au, G, Chu, KW 2005Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapyDis Colon Rectum48218226PubMedCrossRef Law, WL, Ho, JW, Chan, R, Au, G, Chu, KW 2005Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapyDis Colon Rectum48218226PubMedCrossRef
6.
Zurück zum Zitat Norwegian Gastrointestinal Cancer Group1999Colorectal cancer and anal cancer. Guidelines for physicians [in Norwegian]Tidsskr Nor Laegeforen1194143 Norwegian Gastrointestinal Cancer Group1999Colorectal cancer and anal cancer. Guidelines for physicians [in Norwegian]Tidsskr Nor Laegeforen1194143
7.
Zurück zum Zitat Gunderson, LL, Haddock, MG, Schild, SE 2003Rectal cancer: preoperative versus postoperative irradiation as a component of adjuvant treatmentSemin Radiat Oncol13419432PubMedCrossRef Gunderson, LL, Haddock, MG, Schild, SE 2003Rectal cancer: preoperative versus postoperative irradiation as a component of adjuvant treatmentSemin Radiat Oncol13419432PubMedCrossRef
8.
Zurück zum Zitat Stocchi, L, Nelson, H, Sargent, DJ, et al. 2001Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group reportJ Clin Oncol1938953902PubMed Stocchi, L, Nelson, H, Sargent, DJ,  et al. 2001Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group reportJ Clin Oncol1938953902PubMed
9.
Zurück zum Zitat Wibe, A, Rendedal, PR, Svensson, E, et al. 2002Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancerBr J Surg89327334PubMedCrossRef Wibe, A, Rendedal, PR, Svensson, E,  et al. 2002Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancerBr J Surg89327334PubMedCrossRef
10.
Zurück zum Zitat Nagtegaal, ID, Marijnen, CA, Kranenbarg, EK, Velde, CJ, Krieken, JH 2002Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limitAm J Surg Pathol26350357PubMedCrossRef Nagtegaal, ID, Marijnen, CA, Kranenbarg, EK, Velde, CJ, Krieken, JH 2002Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limitAm J Surg Pathol26350357PubMedCrossRef
11.
Zurück zum Zitat Sauer, R, Becker, H, Hohenberger, W, et al. 2004Preoperative versus postoperative chemoradiotherapy for rectal cancerN Engl J Med35117311740PubMedCrossRef Sauer, R, Becker, H, Hohenberger, W,  et al. 2004Preoperative versus postoperative chemoradiotherapy for rectal cancerN Engl J Med35117311740PubMedCrossRef
12.
Zurück zum Zitat Brown, G, Radcliffe, AG, Newcombe, RG, Dallimore, NS, Bourne, MW, Williams, GT 2003Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imagingBr J Surg90355364PubMedCrossRef Brown, G, Radcliffe, AG, Newcombe, RG, Dallimore, NS, Bourne, MW, Williams, GT 2003Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imagingBr J Surg90355364PubMedCrossRef
13.
Zurück zum Zitat Lahaye, MJ, Engelen, SM, Nelemans, PJ, et al. 2005Imaging for predicting the risk factors–the circumferential resection margin and nodal disease–of local recurrence in rectal cancer: a meta-analysisSemin Ultrasound CT MR26259268PubMedCrossRef Lahaye, MJ, Engelen, SM, Nelemans, PJ,  et al. 2005Imaging for predicting the risk factors–the circumferential resection margin and nodal disease–of local recurrence in rectal cancer: a meta-analysisSemin Ultrasound CT MR26259268PubMedCrossRef
14.
Zurück zum Zitat Heald, RJ, Husband, EM, Ryall, RD 1982The mesorectum in rectal cancer surgery–the clue to pelvic recurrence?Br J Surg69613616PubMed Heald, RJ, Husband, EM, Ryall, RD 1982The mesorectum in rectal cancer surgery–the clue to pelvic recurrence?Br J Surg69613616PubMed
15.
Zurück zum Zitat Wibe, A, Eriksen, MT, Syse, A, Myrvold, HE, Soreide, O 2003Total mesorectal excision for rectal cancer - what can be achieved by a national audit?Colorectal Dis5471477PubMedCrossRef Wibe, A, Eriksen, MT, Syse, A, Myrvold, HE, Soreide, O 2003Total mesorectal excision for rectal cancer - what can be achieved by a national audit?Colorectal Dis5471477PubMedCrossRef
16.
Zurück zum Zitat Sobin, LH, Wittekind, Ch 2002UICC: TNM classification of malignant tumors6Wiley-LissNew York Sobin, LH, Wittekind, Ch 2002UICC: TNM classification of malignant tumors6Wiley-LissNew York
17.
Zurück zum Zitat Quirke, P, Dixon, MF 1988The prediction of local recurrence in rectal adenocarcinoma by histopathological examinationInt J Colorectal Dis3127131PubMedCrossRef Quirke, P, Dixon, MF 1988The prediction of local recurrence in rectal adenocarcinoma by histopathological examinationInt J Colorectal Dis3127131PubMedCrossRef
18.
Zurück zum Zitat Eriksen, MT, Wibe, A, Syse, A, Haffner, J, Wiig, JN 2004Inadvertent perforation during rectal cancer resection in NorwayBr J Surg91210216PubMedCrossRef Eriksen, MT, Wibe, A, Syse, A, Haffner, J, Wiig, JN 2004Inadvertent perforation during rectal cancer resection in NorwayBr J Surg91210216PubMedCrossRef
19.
Zurück zum Zitat Colorectal Cancer Collaborative Group2001Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trialsLancet35812911304CrossRef Colorectal Cancer Collaborative Group2001Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trialsLancet35812911304CrossRef
20.
Zurück zum Zitat Camma, C, Giunta, M, Fiorica, F, Pagliaro, L, Craxi, A, Cottone, M 2000Preoperative radiotherapy for resectable rectal cancer: a meta-analysisJAMA28410081015PubMedCrossRef Camma, C, Giunta, M, Fiorica, F, Pagliaro, L, Craxi, A, Cottone, M 2000Preoperative radiotherapy for resectable rectal cancer: a meta-analysisJAMA28410081015PubMedCrossRef
21.
Zurück zum Zitat Gunderson, LL, Sargent, DJ, Tepper, JE, et al. 2004Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysisJ Clin Oncol2217851796PubMedCrossRef Gunderson, LL, Sargent, DJ, Tepper, JE,  et al. 2004Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysisJ Clin Oncol2217851796PubMedCrossRef
22.
Zurück zum Zitat Harewood, GC, Kumar, S, Clain, JE, Levy, MJ, Nelson, H 2004Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound: all T3 rectal cancers are not equalJ Gastroenterol Hepatol19750755PubMedCrossRef Harewood, GC, Kumar, S, Clain, JE, Levy, MJ, Nelson, H 2004Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound: all T3 rectal cancers are not equalJ Gastroenterol Hepatol19750755PubMedCrossRef
23.
Zurück zum Zitat Jatzko, GR, Jagoditsch, M, Lisborg, PH, Denk, H, Klimpfinger, M, Stettner, HM 1999Long-term results of radical surgery for rectal cancer: multivariate analysis of prognostic factors influencing survival and local recurrenceEur J Surg Oncol25284291PubMedCrossRef Jatzko, GR, Jagoditsch, M, Lisborg, PH, Denk, H, Klimpfinger, M, Stettner, HM 1999Long-term results of radical surgery for rectal cancer: multivariate analysis of prognostic factors influencing survival and local recurrenceEur J Surg Oncol25284291PubMedCrossRef
24.
Zurück zum Zitat Merchant, NB, Guillem, JG, Paty, PB, et al. 1999T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapyJ Gastrointest Surg3642647PubMedCrossRef Merchant, NB, Guillem, JG, Paty, PB,  et al. 1999T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapyJ Gastrointest Surg3642647PubMedCrossRef
25.
Zurück zum Zitat Bonadeo, FA, Vaccaro, CA, Benati, ML, Quintana, GM, Garione, XE, Telenta, MT 2001Rectal cancer: local recurrence after surgery without radiotherapyDis Colon Rectum44374379PubMedCrossRef Bonadeo, FA, Vaccaro, CA, Benati, ML, Quintana, GM, Garione, XE, Telenta, MT 2001Rectal cancer: local recurrence after surgery without radiotherapyDis Colon Rectum44374379PubMedCrossRef
26.
Zurück zum Zitat Anonymous1997Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer TrialN Engl J Med336980987CrossRef Anonymous1997Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer TrialN Engl J Med336980987CrossRef
27.
Zurück zum Zitat Mackay, G, Downey, M, Molloy, RG, O’Dwyer, PJ 2006Is pre-operative radiotherapy necessary in T-T rectal cancer with TME?Colorectal Dis83436PubMedCrossRef Mackay, G, Downey, M, Molloy, RG, O’Dwyer, PJ 2006Is pre-operative radiotherapy necessary in T-T rectal cancer with TME?Colorectal Dis83436PubMedCrossRef
28.
Zurück zum Zitat Anonymous1990NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancerJAMA26414441450CrossRef Anonymous1990NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancerJAMA26414441450CrossRef
29.
Zurück zum Zitat Glimelius, B, Gronberg, H, Jarhult, J, Wallgren, A, Cavallin-Stahl, E 2003A systematic overview of radiation therapy effects in rectal cancerActa Oncol42476492PubMedCrossRef Glimelius, B, Gronberg, H, Jarhult, J, Wallgren, A, Cavallin-Stahl, E 2003A systematic overview of radiation therapy effects in rectal cancerActa Oncol42476492PubMedCrossRef
30.
Zurück zum Zitat Beets-Tan, RG, Beets, GL, Vliegen, RF, et al. 2001Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgeryLancet357497504PubMedCrossRef Beets-Tan, RG, Beets, GL, Vliegen, RF,  et al. 2001Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgeryLancet357497504PubMedCrossRef
32.
Zurück zum Zitat Wibe, A, Carlsen, E, Dahl, O, et al. 2006Nationwide quality assurance of rectal cancer treatmentColorectal Dis8224229PubMedCrossRef Wibe, A, Carlsen, E, Dahl, O,  et al. 2006Nationwide quality assurance of rectal cancer treatmentColorectal Dis8224229PubMedCrossRef
33.
Zurück zum Zitat Glimelius, B, Dahl, O, Cedermark, B, et al. 2005Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy GroupActa Oncol44904912PubMedCrossRef Glimelius, B, Dahl, O, Cedermark, B,  et al. 2005Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy GroupActa Oncol44904912PubMedCrossRef
1.
Zurück zum Zitat Church, JM, Raudkivi, PJ, Hill, GL 1987The surgical anatomy of the rectum- a review with particular relevance to the hazards of rectal mobilizationInt J Colorectal Dis2158166PubMedCrossRef Church, JM, Raudkivi, PJ, Hill, GL 1987The surgical anatomy of the rectum- a review with particular relevance to the hazards of rectal mobilizationInt J Colorectal Dis2158166PubMedCrossRef
2.
Zurück zum Zitat Wittekind, CHenson, DEHutter, RV eds. et al. 2001TNM Supplement. A commentary for uniform use2Wiley-LissNew York117119 Wittekind, CHenson, DEHutter, RV eds.  et al. 2001TNM Supplement. A commentary for uniform use2Wiley-LissNew York117119
3.
Zurück zum Zitat Quirke, P, Dixon, MF 1988The prediction of local recurrence in rectal adenocarcinoma by histopathological examinationInt J Colorectal Dis3127131PubMedCrossRef Quirke, P, Dixon, MF 1988The prediction of local recurrence in rectal adenocarcinoma by histopathological examinationInt J Colorectal Dis3127131PubMedCrossRef
4.
Zurück zum Zitat Lahaye, MJ, Engelen, SM, Nelemans, PJ, et al. 2005Imaging for predicting the risk factors—the circumferential resection margin and nodal disease—of local recurrence in rectal cancer: a meta-analysisSemin Ultrasound CT MRI26259268CrossRef Lahaye, MJ, Engelen, SM, Nelemans, PJ,  et al. 2005Imaging for predicting the risk factors—the circumferential resection margin and nodal disease—of local recurrence in rectal cancer: a meta-analysisSemin Ultrasound CT MRI26259268CrossRef
5.
Zurück zum Zitat Beets-Tan, RG, Beets, GL, Vliegen, RF, et al. 2001Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgeryLancet 357497504PubMedCrossRef Beets-Tan, RG, Beets, GL, Vliegen, RF,  et al. 2001Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgeryLancet 357497504PubMedCrossRef
6.
Zurück zum Zitat Nagtegaal, ID, Marijnen, CA, Klein Kranenborg, E, et al. 2002Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one but two mm is the limitAm J Surg Pathol26350357PubMedCrossRef Nagtegaal, ID, Marijnen, CA, Klein Kranenborg, E,  et al. 2002Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one but two mm is the limitAm J Surg Pathol26350357PubMedCrossRef
7.
Zurück zum Zitat Marr, R, Birbeck, K, Garvican, J, et al. 2005The modern abdominoperineal excision. The next challenge after total mesorectal excisionAnn Surg2427482PubMedCrossRef Marr, R, Birbeck, K, Garvican, J,  et al. 2005The modern abdominoperineal excision. The next challenge after total mesorectal excisionAnn Surg2427482PubMedCrossRef
8.
Zurück zum Zitat Nagtegaal, ID, Velde, CJ, Worp, E, et al. 2002Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality controlJ Clin Oncol2017291734PubMedCrossRef Nagtegaal, ID, Velde, CJ, Worp, E,  et al. 2002Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality controlJ Clin Oncol2017291734PubMedCrossRef
9.
Zurück zum Zitat Beets-Tan, RG, Beets, GL 2004Rectal cancer: Review with emphasis on MR imagingRadiology232335346PubMed Beets-Tan, RG, Beets, GL 2004Rectal cancer: Review with emphasis on MR imagingRadiology232335346PubMed
10.
Zurück zum Zitat Merkel, S, Mansmann, U, Siassi, M, et al. 2001The prognostic inhomogeneity in pT3 rectal carcinomasInt J Colorectal Dis16298304PubMedCrossRef Merkel, S, Mansmann, U, Siassi, M,  et al. 2001The prognostic inhomogeneity in pT3 rectal carcinomasInt J Colorectal Dis16298304PubMedCrossRef
11.
Zurück zum Zitat Brown, G, Richards, CJ, Bourne, MW, et al. 2003Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparisonRadiology227371377PubMed Brown, G, Richards, CJ, Bourne, MW,  et al. 2003Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparisonRadiology227371377PubMed
12.
Zurück zum Zitat Sauer, R, Becker, H, Hohenberger, W, et al. 2004Preoperative versus postoperative chemoradiotherapy for rectal cancerN Engl J Med35117311740PubMedCrossRef Sauer, R, Becker, H, Hohenberger, W,  et al. 2004Preoperative versus postoperative chemoradiotherapy for rectal cancerN Engl J Med35117311740PubMedCrossRef
13.
Zurück zum Zitat Sebag-Montefiore D, Steele R, Quirke P, et al. Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomized trial. Proc Am Soc Clin Oncol. J Clin Oncol 2005;24(Suppl):148s abstract 3511 Sebag-Montefiore D, Steele R, Quirke P, et al. Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomized trial. Proc Am Soc Clin Oncol. J Clin Oncol 2005;24(Suppl):148s abstract 3511
14.
Zurück zum Zitat Anonymous1997Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer TrialN Engl J Med336980987CrossRef Anonymous1997Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer TrialN Engl J Med336980987CrossRef
15.
Zurück zum Zitat Kapiteijn, E, Marijnen, CA, Nagtegaal, ID, et al. 2001Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancerN Engl J Med345638646PubMedCrossRef Kapiteijn, E, Marijnen, CA, Nagtegaal, ID,  et al. 2001Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancerN Engl J Med345638646PubMedCrossRef
Metadaten
Titel
Prognostic Groups in 1,676 Patients with T3 Rectal Cancer Treated without Preoperative Radiotherapy
verfasst von
Morten T. Eriksen, M.D.
Arne Wibe, M.D., Ph.D.
Jon Haffner, M.D., Ph.D.
Johan N. Wiig, M.D., Ph.D.
on behalf of The Norwegian Rectal Cancer Group
Publikationsdatum
01.02.2007
Erschienen in
Diseases of the Colon & Rectum / Ausgabe 2/2007
Print ISSN: 0012-3706
Elektronische ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-006-0757-1

Weitere Artikel der Ausgabe 2/2007

Diseases of the Colon & Rectum 2/2007 Zur Ausgabe

OriginalPaper

Selected Abstracts

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.